| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/23/1998 | WO1998031351A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol |
| 07/23/1998 | WO1998031350A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide |
| 07/23/1998 | WO1998031349A1 Transdermal, hormone-delivering therapeutic system |
| 07/23/1998 | WO1998031348A1 Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption |
| 07/23/1998 | WO1998031346A1 Preparation of particles for inhalation |
| 07/23/1998 | WO1998031344A1 Taste masking for unpalatable formulations |
| 07/23/1998 | WO1998031343A2 Aqueous suspension for nasal administration of loteprednol |
| 07/23/1998 | WO1998031339A1 Skin preparation |
| 07/23/1998 | WO1998031227A1 Novel cannabinoid receptor modulators |
| 07/23/1998 | WO1998031225A1 A method of inhibiting or treating phytosterolemia with an mtp inhibitor |
| 07/23/1998 | WO1998031224A1 Method of inhibiting cancer growth |
| 07/23/1998 | WO1998020869A3 Formulation for electrically assisted delivery of lidocaine and epinephrine |
| 07/23/1998 | WO1998020866A3 Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists |
| 07/23/1998 | WO1998020865A3 Therapeutic uses for nitric oxide inhibitors |
| 07/23/1998 | WO1998018500A3 Improvements in or relating to diagnostic/therapeutic agents |
| 07/23/1998 | WO1998018493A3 Conjugates useful in the treatment of prostate cancer |
| 07/23/1998 | DE19701694A1 Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung Recent modifications of 2-amino-4- (4-fluorobenzylamino) -l-ethoxycarbonyl-diaminobenzene as well as processes for their preparation |
| 07/23/1998 | DE19701692A1 Anticancer pharmaceutical composition |
| 07/23/1998 | DE19701619A1 Verwendung von Pramipexol zur Behandlung des restless legs syndroms Use of pramipexole in the treatment of restless legs syndrome |
| 07/23/1998 | DE19701264A1 Heilmittel, enthaltend Betasitosterin und/oder Phytosterol/Betasitosteringemische Remedies containing betasitosterol and / or phytosterol / Betasitosteringemische |
| 07/23/1998 | CA2419499A1 Crystal form 0 of clarithromycin |
| 07/23/1998 | CA2278452A1 Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors) |
| 07/23/1998 | CA2278450A1 Microparticles for delivery of nucleic acid |
| 07/23/1998 | CA2278424A1 Process for preparing indane-like compounds |
| 07/23/1998 | CA2278309A1 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
| 07/23/1998 | CA2278307A1 Novel cannabinoid receptor modulators |
| 07/23/1998 | CA2278220A1 Use of .beta.3-adrenergic receptor agonists for the preparation of healing drugs |
| 07/23/1998 | CA2278023A1 Modulators of insulin receptor activity |
| 07/23/1998 | CA2277929A1 Thrombin inhibitors |
| 07/23/1998 | CA2277924A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 07/23/1998 | CA2277831A1 Taste masking for unpalatable formulations |
| 07/23/1998 | CA2277480A1 Paroxetine compositions |
| 07/23/1998 | CA2277366A1 Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption |
| 07/23/1998 | CA2277230A1 Method of treating herpes infections |
| 07/23/1998 | CA2277053A1 Method of treating rhinoviral infections |
| 07/23/1998 | CA2277042A1 Aromatic tetracyclic compounds of the retinoid type, method for preparing and use |
| 07/23/1998 | CA2276783A1 Use of .delta.5 androstenes in the treatment of hiv wasting syndrome |
| 07/23/1998 | CA2276758A1 Dosage forms and method for ameliorating male erectile dysfunction |
| 07/23/1998 | CA2276467A1 Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs |
| 07/23/1998 | CA2276111A1 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/23/1998 | CA2274889A1 Bis-sulfonomides hydroxamic acids as mmp inhibitors |
| 07/23/1998 | CA2249529A1 New triazoles as therapeutic agents for fungal infections |
| 07/22/1998 | EP0854191A2 Human cardiac/brain tolloid-like protein |
| 07/22/1998 | EP0854146A1 Substituted 4-(6-fluoro-[1H]-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders |
| 07/22/1998 | EP0854145A2 Vitronectin receptor antagonists, their production and their use |
| 07/22/1998 | EP0854140A2 Vitronectin receptor antagonists, their production and their use |
| 07/22/1998 | EP0853764A1 Combinatorial synthesis and high-throughput screening of a rev-inhibiting arylidenediamide array |
| 07/22/1998 | EP0853681A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
| 07/22/1998 | EP0853673A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 07/22/1998 | EP0853669A2 A gene associated with liver neoplastic disease |
| 07/22/1998 | EP0853667A2 Bone stimulating factor |
| 07/22/1998 | EP0853661A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 07/22/1998 | EP0853629A1 Hepadnavirus receptor |
| 07/22/1998 | EP0853628A1 Photolabile 8-substituted cyclic nucleotide esters, methods of preparing them and their use |
| 07/22/1998 | EP0853627A1 Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| 07/22/1998 | EP0853626A1 Substituted phosphinic compounds and their use as pharmaceuticals |
| 07/22/1998 | EP0853623A1 Enediyne compounds |
| 07/22/1998 | EP0853622A1 PROCESS FOR PREPARING 1-ARYL-4-OXOPYRROLO 3,2-c]QUINOLINE DERIVATIVES |
| 07/22/1998 | EP0853621A1 Novel substituted azacyclic or azabicyclic compounds |
| 07/22/1998 | EP0853619A1 Disubstituted piperidine derivatives |
| 07/22/1998 | EP0853618A1 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n- (aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
| 07/22/1998 | EP0853617A1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 07/22/1998 | EP0853616A1 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 07/22/1998 | EP0853615A1 Piperidine compounds as calcium channel blockers |
| 07/22/1998 | EP0853614A1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors |
| 07/22/1998 | EP0853610A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 07/22/1998 | EP0853486A2 Therapeutic applications of animal sera including horse serum in the treatment of aids, cancer, and other viral and bacterial diseases |
| 07/22/1998 | EP0853485A1 Therapeutic administration of hemoglobin in cardiac arrest |
| 07/22/1998 | EP0853481A1 Compositions for treating inflammation containing certain prostaglandins and a selective cyclooxygenase-2 inhibitor |
| 07/22/1998 | EP0853480A1 Use of a thienotriazolodiazepine to increase apolipoprotein a-i levels |
| 07/22/1998 | EP0853479A1 ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS |
| 07/22/1998 | EP0853478A1 New n-acylated 4-hydroxyphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them |
| 07/22/1998 | EP0853477A1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys |
| 07/22/1998 | EP0853476A2 Pharmaceutical preparation containing nimesulide for topical use |
| 07/22/1998 | EP0853475A1 Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products |
| 07/22/1998 | EP0853472A1 Use of carbohydrates for promoting skin exfoliation |
| 07/22/1998 | EP0794767B1 Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams |
| 07/22/1998 | EP0783500B1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 07/22/1998 | EP0766695B1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 07/22/1998 | EP0748312B1 Bicyclic carbamates as leukotriene d4 antagonists |
| 07/22/1998 | EP0736025B1 Dyhydrobenzofuranyl-biphenyl carboxamides having 5ht1d antagonistic activity |
| 07/22/1998 | EP0725775B1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands |
| 07/22/1998 | EP0700249B1 Anti-infective agents |
| 07/22/1998 | EP0698014B1 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or cck antagonists |
| 07/22/1998 | EP0691959B1 Heterocyclic derivatives as platelet aggregation inhibitors |
| 07/22/1998 | EP0677042B1 Selective ligands of 5ht1d-5ht1b receptors derived from indole-piperazine useful as medicaments |
| 07/22/1998 | EP0667914B1 Fo-1289 substance and its production |
| 07/22/1998 | EP0656029B1 Crosslinked polymeric ammonium salts |
| 07/22/1998 | EP0655070B1 Triantennary cluster glycosides, their preparation and use |
| 07/22/1998 | EP0643767B1 Osteogenic peptides |
| 07/22/1998 | EP0630893B1 N,n'-disubstituted amide derivative |
| 07/22/1998 | EP0601191B1 Novel tetracyclic compound |
| 07/22/1998 | EP0575613B1 Use of the amino acid glycine for the preparation of a medicament with antistress-, stress-preventive and nootropic action |
| 07/22/1998 | EP0557385B1 Topical compositions for transdermal delivery of produg derivatives of morphine |
| 07/22/1998 | EP0517859B1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 07/22/1998 | EP0486561B2 Buccal composition containing s(+) ketoprofen |
| 07/22/1998 | EP0462964B1 Topical compositions containing aliphatic amines for the treatment of skin diseases |
| 07/22/1998 | CN1188512A Efflux pump inhibitors |
| 07/22/1998 | CN1188482A Colchicine derivatives, use thereof and formulations containing them |
| 07/22/1998 | CN1188478A Azacycloalcane derivatives, preparation thereof and their applications in therapy |